The impact of specific mutations in TP53 gene on the results of alemtuzumab therapy in chronic lymphocytic leukemia patients

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	DOUBEK Michael TRBUŠEK Martin MALČÍKOVÁ Jitka BRYCHTOVÁ Yvona ŠMARDOVÁ Jana LOCHMANOVÁ Jana PANOVSKÁ Anna SKUHROVÁ FRANCOVÁ Hana MRÁZ Marek TICHÝ Boris ŠEBEJOVÁ Ludmila DOBEŠ Petr PLEVOVÁ Karla VAŇKOVÁ Gabriela KUGLÍK Petr MAYER Jiří POSPÍŠILOVÁ Šárka
Year of publication	2011
Type	Conference abstract
MU Faculty or unit	Central European Institute of Technology
Citation
Related projects:	Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies Real-time PCR soupravy pro diagnostiku v onkologii Funkční a strukturní změny microRNA u lymfoproliferativních malignit a jejich vliv na prognózu onemocnění a predikci léčebné odpovědi